Gisondi, P., Loconsole, F., Raimondo, P. and Ravasio, R. (2021) “Cost per responder for risankizumab vs secukinumab in patients with moderate-to-severe plaque psoriasis in Italy”, Global and Regional Health Technology Assessment, 8(1), pp. 120–130. doi: 10.33393/grhta.2021.2258.